Catalent Future Growth
Future criteria checks 4/6
Catalent is forecast to grow earnings and revenue by 92.2% and 7.2% per annum respectively. EPS is expected to grow by 92.1% per annum. Return on equity is forecast to be 7.6% in 3 years.
Key information
92.2%
Earnings growth rate
92.1%
EPS growth rate
Pharmaceuticals earnings growth | 20.7% |
Revenue growth rate | 7.2% |
Future return on equity | 7.6% |
Analyst coverage | Good |
Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 4,973 | 217 | 187 | 651 | 8 |
6/30/2025 | 4,656 | 78 | 154 | 563 | 11 |
6/30/2024 | 4,398 | -816 | -163 | 475 | 8 |
12/31/2023 | 4,098 | -1,302 | -263 | 174 | N/A |
9/30/2023 | 4,223 | -1,015 | -235 | 276 | N/A |
6/30/2023 | 4,263 | -256 | -322 | 254 | N/A |
3/31/2023 | 4,495 | 21 | -563 | 127 | N/A |
12/31/2022 | 4,731 | 389 | -371 | 329 | N/A |
9/30/2022 | 4,799 | 399 | -471 | 184 | N/A |
6/30/2022 | 4,802 | 483 | -221 | 439 | N/A |
3/31/2022 | 4,703 | 485 | -110 | 504 | N/A |
12/31/2021 | 4,483 | 561 | -183 | 441 | N/A |
9/30/2021 | 4,177 | 544 | -244 | 446 | N/A |
6/30/2021 | 3,998 | 529 | -253 | 433 | N/A |
3/31/2021 | 3,757 | 494 | -188 | 471 | N/A |
12/31/2020 | 3,465 | 289 | -135 | 518 | N/A |
9/30/2020 | 3,275 | 250 | 22 | 565 | N/A |
6/30/2020 | 3,094 | 173 | -26 | 440 | N/A |
3/31/2020 | 2,872 | 104 | -37 | 356 | N/A |
12/31/2019 | 2,729 | 124 | 20 | 309 | N/A |
9/30/2019 | 2,631 | 138 | -22 | 232 | N/A |
6/30/2019 | 2,518 | 132 | 30 | 248 | N/A |
3/31/2019 | 2,478 | 149 | 75 | 263 | N/A |
12/31/2018 | 2,488 | 136 | 108 | 283 | N/A |
9/30/2018 | 2,471 | 65 | 160 | 332 | N/A |
6/30/2018 | 2,463 | 84 | 198 | 375 | N/A |
3/31/2018 | 2,395 | 63 | 202 | 371 | N/A |
12/31/2017 | 2,300 | 70 | 211 | 380 | N/A |
9/30/2017 | 2,177 | 109 | N/A | 335 | N/A |
6/30/2017 | 2,075 | 110 | N/A | 300 | N/A |
3/31/2017 | 1,991 | 106 | N/A | 233 | N/A |
12/31/2016 | 1,896 | 91 | N/A | 180 | N/A |
9/30/2016 | 1,867 | 104 | N/A | 159 | N/A |
6/30/2016 | 1,848 | 112 | N/A | 155 | N/A |
3/31/2016 | 1,826 | 207 | N/A | 199 | N/A |
12/31/2015 | 1,835 | 228 | N/A | 243 | N/A |
9/30/2015 | 1,836 | 244 | N/A | 257 | N/A |
6/30/2015 | 1,831 | 212 | N/A | 172 | N/A |
3/31/2015 | 1,840 | 86 | N/A | 180 | N/A |
12/31/2014 | 1,847 | 62 | N/A | 138 | N/A |
9/30/2014 | 1,832 | -3 | N/A | 113 | N/A |
6/30/2014 | 1,828 | 19 | N/A | 178 | N/A |
3/31/2014 | 1,813 | 2 | N/A | 148 | N/A |
12/31/2013 | 1,807 | -20 | N/A | 152 | N/A |
9/30/2013 | 1,803 | -29 | N/A | 151 | N/A |
6/30/2013 | 1,800 | -51 | N/A | 138 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0C8 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: 0C8 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0C8 is expected to become profitable in the next 3 years.
Revenue vs Market: 0C8's revenue (7.2% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 0C8's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0C8's Return on Equity is forecast to be low in 3 years time (7.6%).